West Pharmaceutical Services Inc (WST) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 8-K - Current report

West Announces Leadership Changes

West Announces Leadership Changes PR Newswire EXTON, Pa., April 24, 2025 Bernard J. Birkett Announces...

West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend

West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter...

Form 8-K - Current report

West to Host First-Quarter 2025 Conference Call

West to Host First-Quarter 2025 Conference Call PR Newswire EXTON, Pa., April 10, 2025 EXTON, Pa., April 10...

Form 4 - Statement of changes in beneficial ownership of securities

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

West to Participate in Upcoming Investor Conferences

West to Participate in Upcoming Investor Conferences PR Newswire EXTON, Pa., March 5, 2025 EXTON, Pa., March...